ASND icon

Ascendis Pharma

244 hedge funds and large institutions have $10.9B invested in Ascendis Pharma in 2025 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 83 increasing their positions, 85 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
244
Holders Change
+3
Holders Change %
+1.24%
% of All Funds
3.28%
Holding in Top 10
16
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+14.29%
% of All Funds
0.21%
New
44
Increased
83
Reduced
85
Closed
40
Calls
$39.2M
Puts
$12.6M
Net Calls
+$26.6M
Net Calls Change
+$41.1M
Name Holding Trade Value Shares
Change
Shares
Change %
AAP
226
Arax Advisory Partners
Colorado
$9.32K +$9.32K +54 New
WTA
227
Washington Trust Advisors
Massachusetts
$8.98K
BC
228
Bayforest Capital
United Kingdom
$8.8K +$8.8K +51 New
HCM
229
Hollencrest Capital Management
California
$8.29K
CFB
230
Cullen/Frost Bankers
Texas
$7.77K
RF
231
Roxbury Financial
New Jersey
$7.25K +$5.52K +32 +320%
TC
232
Truvestments Capital
Florida
$6.39K
OWP
233
ORG Wealth Partners
Texas
$4.3K +$4.3K +25 New
BAM
234
Bellevue Asset Management
Washington
$3.28K
GRP
235
Global Retirement Partners
California
$2.42K +$2.42K +14 New
PWA
236
Physician Wealth Advisors
Utah
$1.73K
AF
237
Allworth Financial
California
$1.73K +$1.73K +10 New
MCM
238
MAI Capital Management
Ohio
$1.21K
PS
239
Principal Securities
Iowa
$1.21K +$173 +1 +17%
SPIA
240
Steward Partners Investment Advisory
New York
$1.21K +$1.21K +7 New
OP
241
ORG Partners
Indiana
$1.03K
SS
242
SBI Securities
Japan
$518
BI
243
Binnacle Investments
Iowa
$518
W
244
WealthCollab
Washington
$518
TPCW
245
TD Private Client Wealth
New York
$345
Point72 Asset Management
246
Point72 Asset Management
Connecticut
-$88.7M -569,146 Closed
FC
247
Finepoint Capital
Massachusetts
-$28M -179,872 Closed
DFO
248
Duquesne Family Office
New York
-$24.7M -158,720 Closed
B
249
Braidwell
Connecticut
-$16.6M -106,713 Closed
IHAM
250
Integral Health Asset Management
New York
-$15.6M -100,000 Closed